REGENXBIO Up Over 17%, on Track for Largest Percent Increase Since November 2024 -- Data Talk

Dow Jones
03/10

REGENXBIO, Inc. $(RGNX)$ is currently at $10.16, up $1.51 or 17.46%

 

--Would be highest close since Feb. 9, 2026, when it closed at $10.31

--On pace for largest percent increase since Nov. 7, 2024, when it rose 18.66%

--Snaps a two day losing streak

--Up 12.39% month-to-date

--Down 29.44% year-to-date

--Down 87.63% from its all-time closing high of $82.15 on July 10, 2018

--Up 69.05% from 52 weeks ago (March 10, 2025), when it closed at $6.01

--Down 36.42% from its 52-week closing high of $15.98 on Jan. 22, 2026

--Up 91.34% from its 52-week closing low of $5.31 on April 8, 2025

--Traded as high as $10.76; highest intraday level since Feb. 6, 2026, when it hit $10.95

--Up 24.39% at today's intraday high; largest intraday percent increase since March 5, 2024, when it rose as much as 34.83%

 

All data as of 2:42:17 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

March 09, 2026 14:45 ET (18:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10